| Product NDC: | 27437-207 |
| Proprietary Name: | SUPRAX |
| Non Proprietary Name: | cefixime |
| Active Ingredient(s): | 500 mg/5mL & nbsp; cefixime |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 27437-207 |
| Labeler Name: | LUPIN PHARMA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202091 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130315 |
| Package NDC: | 27437-207-02 |
| Package Description: | 10 mL in 1 BOTTLE (27437-207-02) |
| NDC Code | 27437-207-02 |
| Proprietary Name | SUPRAX |
| Package Description | 10 mL in 1 BOTTLE (27437-207-02) |
| Product NDC | 27437-207 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cefixime |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20130315 |
| Marketing Category Name | NDA |
| Labeler Name | LUPIN PHARMA |
| Substance Name | CEFIXIME |
| Strength Number | 500 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |